WEDNESDAY, Feb. 22, 2023 (HealthDay News) — A new study links obesity with 21 Alzheimer’s disease-related genes. This may help explain why Alzheimer’s is often more frequent among adults who experienced obesity in midlife, according to researchers at the University of Texas Health Science Center at San Antonio. To studyContinue Reading
TUESDAY, Feb. 14, 2023 (HealthDay News) — What do race and early education have to do with dementia risk among seniors? Quite a bit, a new study suggests. Researchers spent decades tracking the onset of dementia among nearly 21,000 U.S. seniors, before reaching two main conclusions. The first is thatContinue Reading
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — Seniors who frequently take sleeping medications may be raising their risk for developing Alzheimer’s disease, a new study warns. Sleep medications are one of the most commonly used medications in older adults, the authors say, but their frequent use may not be withoutContinue Reading
TUESDAY, Jan. 31, 2023 (HealthDay News) — Tying the knot is now tied to healthier aging brains: People who stay married for the long haul may gain some protection from dementia, a new study suggests. Researchers found that compared with both divorced people and lifelong singles, older adults in aContinue Reading
FRIDAY, Jan. 27, 2023 (HealthDay News) — Winter weather can add a layer of danger to the wandering behavior common in people with dementia. The Alzheimer’s Foundation of America (AFA) offers some suggestions to help prevent wandering and prepare folks to react quickly if it occurs. “During the winter, it’sContinue Reading
THURSDAY, Jan. 26, 2023 (HealthDay News) — A lot of people wear watches that count their every step as they try to move more. Now, a new study finds that getting more of those steps each day, along with moderate-to-vigorous physical exercise, could cut the risk of dementia and thinkingContinue Reading
THURSDAY, Jan. 26, 2023 (HealthDay News) — A good physical workout benefits an older brain. So does socializing. Put those two together and the payoff may be even bigger. Researchers in Japan found that link in a new study that looked at exercising solo and in a group. “Exercise isContinue Reading
WEDNESDAY, Jan. 25, 2023 (HealthDay News) — Memory loss is the most common symptom associated with Alzheimer’s disease — the terrifying prospect of slowly forgetting yourself and everything around you. But people who exhibit memory loss early on in their dementia actually have a slower rate of decline than thoseContinue Reading
TUESDAY, Jan. 17, 2023 (HealthDay News) — Could losing your hearing as you age be a harbinger of dementia? Maybe, suggests new research that found that older people who had trouble hearing were more likely to develop dementia down the road. But there’s good news with the bad: Hearing aidsContinue Reading
FRIDAY, Jan. 13, 2023 (HealthDay News) — Social isolation is a substantial risk factor for dementia in older adults, according to a pair of studies that add evidence to past research on this threat. But these new studies offer a potential solution: using technology to encourage older adults to textContinue Reading
THURSDAY, Jan. 12, 2023 (HealthDay News) — Six minutes of high-intensity exercise might prolong the lifespan of a healthy brain, perhaps delaying the start of Alzheimer’s and Parkinson’s diseases, a new, small study suggests. Researchers found that short but intense cycling increased the production of a protein called brain-derived neurotrophicContinue Reading
FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitatesContinue Reading
THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug hasContinue Reading
THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s approval process for the controversial Alzheimer’s drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to slow the disease down, a Congressional report released Thursday claims. Actions the agency tookContinue Reading